InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,304.80
(
2.37%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.10
(
-0.30%
)
Bitcoin
63,848.29
(
1.43%
)
Post# of 197569
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

pivotpoint1

Send PM Follow Ignore
Followers 280
Posts 59167
Boards Moderated 0
Alias Born 02/15/2012

pivotpoint1

Re: None

Monday, 08/15/2016 10:29:47 AM

Monday, August 15, 2016 10:29:47 AM

Post# of 197569
ARTH ~ "These results demonstrate significant improvement in efficacy without compromising patient safety. We believe that AC5 represents a unique technology that will provide both rapid and sustained hemostasis and important differentiable clinical benefits," concluded Norchi."

~With news like this it's no wonder there is so much interest-

https://finance.yahoo.com/news/arch-therapeutics-reports-ac5-topical-105700951.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up